EPISODE · Jun 4, 2022 · 6 MIN
[Event: ASCO] Jen-Tang Lu of Vysioneer
from Microdosing · host Paul Schrimpf
Jen-Tang Lu of Vysioneer shares shares how they are using AI to unlock real-world guideline-based tumor response assessments, and improve clinical trials in that space.
What this episode covers
Jen-Tang Lu of Vysioneer shares shares how they are using AI to unlock real-world guideline-based tumor response assessments, and improve clinical trials in that space.
NOW PLAYING
[Event: ASCO] Jen-Tang Lu of Vysioneer
No transcript for this episode yet
Similar Episodes
Jun 10, 2026 ·121m
Jun 5, 2026 ·42m
May 20, 2026 ·58m